SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide. It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells. The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas. In addition, it provides contract chemistry, molecular biology, multidisciplinary in vivo diagnostics and monitoring solutions development, comparative studies of biosimilar products, and early-stage in vivo and in vitro diagnostic technologies scale-up and commercialization services, as well as undertakes integrated multiple key-steps pre-clinical discovery projects. The company was founded in 2013 and is based in Lublin, Poland.
Metrics to compare | SDSP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSDSPPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −11.6x | −0.6x | |
PEG Ratio | 0.00 | 0.09 | 0.00 | |
Price/Book | 0.0x | 3.2x | 2.6x | |
Price / LTM Sales | 0.0x | 7.4x | 3.0x | |
Upside (Analyst Target) | 0.0% | 47.6% | 51.6% | |
Fair Value Upside | Unlock | 4.9% | 9.3% | Unlock |